TELO (Telomir Pharmaceuticals Inc) vs S&P 500 Comparison

TELO

S&P 500

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

TELO

S&P 500

Difference

1Y 3Y 5Y 10Y 15Y 20Y

TELO

S&P 500

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

S&P 500

TELO

LLY

DPH

NOVO B

JNJ

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Telomir Pharmaceuticals Inc
Glance View

Market Cap

126.4m USD

Industry

Pharmaceuticals

Telomir Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Tampa, Florida and currently employs 2 full-time employees. The company went IPO on 2024-02-09. Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company. The firm is focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. TELOMIR-1 serve as a metal enzyme inhibitor of essential metals such as zinc and copper. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The Company’s BioMAP platform provides an unbiased, target-agnostic, and data-driven approach to understanding the effect of mono- or combination therapies on human disease models and translational biomarkers.

View TELO Analysis

TELO Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Add
US		Eli Lilly and Co NYSE:LLY	Add
UK		Dechra Pharmaceuticals PLC LSE:DPH	Add
DK		Novo Nordisk A/S CSE:NOVO B	Add
US		Johnson & Johnson NYSE:JNJ	Add
US		Merck & Co Inc NYSE:MRK	Add
CH		Roche Holding AG SIX:ROG	Add
UK		AstraZeneca PLC LSE:AZN	Add
CH		Novartis AG SIX:NOVN	Add
US		Pfizer Inc NYSE:PFE	Add

JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Select
US		Eli Lilly and Co NYSE:LLY	Select
UK		Dechra Pharmaceuticals PLC LSE:DPH	Select
DK		Novo Nordisk A/S CSE:NOVO B	Select
US		Johnson & Johnson NYSE:JNJ	Select
US		Merck & Co Inc NYSE:MRK	Select
CH		Roche Holding AG SIX:ROG	Select
UK		AstraZeneca PLC LSE:AZN	Select
CH		Novartis AG SIX:NOVN	Select
US		Pfizer Inc NYSE:PFE	Select

JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Add
US		Eli Lilly and Co NYSE:LLY	Add
UK		Dechra Pharmaceuticals PLC LSE:DPH	Add
DK		Novo Nordisk A/S CSE:NOVO B	Add
US		Johnson & Johnson NYSE:JNJ	Add
US		Merck & Co Inc NYSE:MRK	Add
CH		Roche Holding AG SIX:ROG	Add
UK		AstraZeneca PLC LSE:AZN	Add
CH		Novartis AG SIX:NOVN	Add
US		Pfizer Inc NYSE:PFE	Add

	Franklin Covey Co NYSE:FC	32.32 USD -8.44%
	Mohawk Industries Inc NYSE:MHK	118.51 USD 0.19%
	Ardmore Shipping Corp NYSE:ASC	13.335 USD 6.17%
	ASGN Inc NYSE:ASGN	85.53 USD -1.6%
	Skyworks Solutions Inc NASDAQ:SWKS	93.32 USD 0.74%
	Weatherford International PLC NASDAQ:WFRD	73.9 USD 2.45%

	Johnson & Johnson NYSE:JNJ	142.56 USD 0.2%
	Bank of America Corp NYSE:BAC	45.315 USD -1.94%
	Mastercard Inc NYSE:MA	507.07 USD -1.81%
	Salesforce Inc NYSE:CRM	318.565 USD -2.55%
	Abbvie Inc NYSE:ABBV	176.46 USD -1.14%
	Home Depot Inc NYSE:HD	387.18 USD -0.01%

TELO

vs

S&P 500

Stocks Performance
TELO vs S&P 500

Performance Gap
TELO vs S&P 500

Performance By Year
TELO vs S&P 500

Competitors Performance
Telomir Pharmaceuticals Inc vs Peers

Telomir Pharmaceuticals Inc
Glance View

Company

Help

Tools

Stocks

US	G	GE Vernova LLC NYSE:GEV	Add
NL	N	Nepi Rockcastle NV JSE:NRP	Add
US		Schlumberger NV NYSE:SLB	Add
US	B	Baker Hughes Co NASDAQ:BKR	Add
ID		Amman Mineral Internasional Tbk PT IDX:AMMN	Add
US	R	Reddit Inc NYSE:RDDT	Add
CH	G	Galderma Group AG SIX:GALD	Add
US		Halliburton Co NYSE:HAL	Add
LU		Tenaris SA MIL:TEN	Add
IN		Jio Financial Services Ltd NSE:JIOFIN	Add

	Arista Networks Inc NYSE:ANET	113.19 USD -2.01%
	Visa Inc NYSE:V	307.83 USD -1.53%
	Texas Pacific Land Corp NYSE:TPL	1 294.57 USD 1.46%
	KLA Corp NASDAQ:KLAC	679.47 USD -0.98%
	Manhattan Associates Inc NASDAQ:MANH	266.61 USD -2.16%
	Pinduoduo Inc NASDAQ:PDD	95.95 USD -4.36%

	Salesforce Inc NYSE:CRM	318.565 USD -2.55%
	ServiceNow Inc NYSE:NOW	1 020.955 USD -2.68%
	EOG Resources Inc NYSE:EOG	132.21 USD 2.92%
	Copart Inc NASDAQ:CPRT	55.88 USD -1.59%
	Applied Materials Inc NASDAQ:AMAT	171.1268 USD -3.31%
	Synopsys Inc NASDAQ:SNPS	493.44 USD -1.71%

	Johnson & Johnson NYSE:JNJ	142.56 USD 0.2%
	Berkshire Hathaway Inc NYSE:BRK.A	668 439.5 USD -1.4%
	Bank of America Corp NYSE:BAC	45.315 USD -1.94%
	Mastercard Inc NYSE:MA	507.07 USD -1.81%
	UnitedHealth Group Inc NYSE:UNH	529.55 USD 0.96%
	Exxon Mobil Corp NYSE:XOM	107.615 USD 0.64%

TELO vs S&P 500

Stocks Performance TELO vs S&P 500

Performance Gap TELO vs S&P 500

Performance By Year TELO vs S&P 500

Competitors Performance Telomir Pharmaceuticals Inc vs Peers

Telomir Pharmaceuticals Inc Glance View

Company

Help

Tools

Stocks

TELO

vs

S&P 500

Stocks Performance
TELO vs S&P 500

Performance Gap
TELO vs S&P 500

Performance By Year
TELO vs S&P 500

Competitors Performance
Telomir Pharmaceuticals Inc vs Peers

Telomir Pharmaceuticals Inc
Glance View